Power first, models second AI is no longer constrained primarily by algorithms or capital; it is constrained by electrons.
German pharmaceutical company Merck signed a contract worth 4 trillion Korean won on the 20th to adopt the AI-based new drug development platform of U.S. bio company Valo Health. A source from Merck ...